Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) EBITDA Margin (2024 - 2025)

Historic EBITDA Margin for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to 140.73%.

  • Kestra Medical Technologies' EBITDA Margin fell 106500.0% to 140.73% in Q4 2025 from the same period last year, while for Oct 2025 it was 174.32%, marking a year-over-year decrease of 44000.0%. This contributed to the annual value of 177.85% for FY2025, which is 1279800.0% up from last year.
  • Kestra Medical Technologies' EBITDA Margin amounted to 140.73% in Q4 2025, which was down 106500.0% from 149.08% recorded in Q3 2025.
  • In the past 5 years, Kestra Medical Technologies' EBITDA Margin registered a high of 130.07% during Q4 2024, and its lowest value of 279.77% during Q2 2025.